Farther Finance Advisors, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1992825 SAN FRANCISCO, CA

Position in BMRN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$450,378

+$6,537 QoQ

Shares Held

7,871

+0.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#350

of 561 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. BMRN ranks #8 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc This page	7,871	$450,378

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$450,378	7,871	+0.2%	Shares	Sole	2026-07-17
2026-03-31	$443,841	7,857	+79.7%	Shares	Sole	2026-04-07
2025-12-31	$259,887	4,373	+977.1%	Shares	Sole	2026-01-23
2025-09-30	$21,988	406	+65.7%	Shares	Sole	2025-10-14
2025-06-30	$13,467	245	-43.2%	Shares	Sole	2025-07-11
2025-03-31	$30,467	431	+95.9%	Shares	Sole	2025-04-14
2024-12-31	$14,460	220	+144.4%	Shares	Sole	2025-02-10
2024-09-30	$6,326	90	+2.3%	Shares	Sole	2024-10-29
2024-06-30	$7,245	88	-30.2%	Shares	Sole	2024-07-31
2024-03-31	$11,004	126	-14.9%	Shares	Sole	2024-05-14
2023-12-31	$14,270	148	+311.1%	Shares	Sole	2024-02-15
2023-09-30	$3,185	36	+227.3%	Shares	Sole	2023-11-14
2022-12-31	$1,138	11	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.